Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological advances in drug development
3.2.1.2 Growing investments and research grants for developing alternative technologies
3.2.1.3 Increasing ban on using animal models for research purposes
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulations related to safety, efficacy and quality
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players: Cell line
4.4 Competitive analysis of major market players: Tissue line
4.5 Competitive analysis of major market players: Organ-on-chips
4.6 Competitive positioning matrix
4.7 Strategy dashboard
4.8 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Organ-on-chips
5.3 Cell lines
5.4 Tissue lines
Chapter 6 Market Estimates and Forecast, By Method, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Ex vivo testing
6.3 Computer modelling
6.4 Cellular assay
6.5 Biochemical assay
Chapter 7 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cell culture technology
7.3 High throughput technology
7.4 Molecular imaging technology
7.5 Omics technology
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Infectious diseases
8.3 Immunological diseases
8.4 Oncology
8.5 Cardiovascular diseases
8.6 Diabetes
8.7 Genetic diseases
8.8 Neurological diseases
Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical companies
9.3 Biotechnological companies
9.4 Research institutes and academics
9.5 CROs
9.6 Other end users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
Chapter 11 Company Profiles
11.1 AlveoliX
11.2 BICO GROUP
11.3 CN Bio Innovations
11.4 Emulate
11.5 Hesperos
11.6 InSphero
11.7 Lonza Group
11.8 Merck
11.9 MIMETAS
11.10 Thermo Fisher Scientific
11.11 TissUse
11.12 VITROCELL Systems
